Padeliporfin
Tookad (padeliporfin) is a small molecule pharmaceutical. Padeliporfin was first approved as Tookad on 2017-11-10. It has been approved in Europe to treat prostatic neoplasms.
| Trade Name | Tookad |
|---|---|
| Common Name | Padeliporfin |
| Indication | prostatic neoplasms |
| Drug Class | Benzoporphyrin derivatives |
